You have 9 free searches left this month | for more free features.

Condition

Breast Cancer (1)

Esophageal Cancer (1)

Gastric Cancer (1)

Non Small Cell Lung Cancer (1)

Overall Status

Completed (2)

Withdrawn (1)

Sign in for free

Phase

phase 2 (1)

phase 4 (1)

Sponsor

Centre Hospitalier Annecy Genevois (1)

Dana-Farber Cancer Institute (1)

Hoffmann-La Roche (1)

Collaborator

Beth Israel Deaconess Medical Center (1)

Brigham and Women's Hospital (1)

Genentech, Inc. (1)

Massachusetts General Hospital (1)

Sanofi (1)

University Hospital, Grenoble (1)

Intervention

bevacizumab (1)

bevacizumab [avastin] (1)

docetaxel (1)

paclitaxel (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Observational (1)

AvaTax

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Esophageal Cancer, Gastric Cancer Trial in Boston (Docetaxel, Bevacizumab)

Completed

Esophageal Cancer
Gastric Cancer

Boston, Massachusetts
+2 more

Oct 31, 2018

Paclitaxel in Combination With Bevacizumab in Stage IV NSCLC.

Completed

Non Small Cell Lung Cancer

Boulogne Billancourt, France
+14 more

Nov 20, 2020

Breast Cancer Trial (bevacizumab [Avastin], paclitaxel)

Withdrawn

Breast Cancer

bevacizumab [Avastin]
paclitaxel

(no location specified)

Nov 1, 2016